Thomas Smith

Q: What is Thomas Smith's success rate?

Thomas Smith currently has a success rate of 74.35867679505873.

Q: What is the average return of Thomas Smith's calls?

Their stock ratings have generated an average return of 29.039973583545255.

Leerink Partners | Healthcare

Thomas Smith is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #1171 out of 4691 analysts, they have issued 10 stock ratings with a success rate of 74.36% and an average return of 29.04%.

With 10 ratings to date, Thomas Smith is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 74.36% and an average return of 29.04%, highlighting promising potential as their track record develops further.

#1171

Out of 4691

Total Ratings

+74.36%

Success Rate

+29.04%

Average Return

Recent Ratings Analysis

ALT

Buy

Jun 22, 2026

Target

$10.00

Current

$2.93

Performance

0.00%

Thomas Smith rated ALT as Outperform on Jun 22, 2026, setting a price target of 10. Shares have remained stable near 2.93, leaving the 10 target still in play.

SABS

Buy

Jun 15, 2026

Target

$12.00

Current

$3.93

Performance

0.77%

On Jun 15, 2026, SABS was given a Outperform rating by Thomas Smith, with a target price of 12. The stock traded sideways with a 0.77% move, keeping the bullish thesis unresolved.

XFOR

Buy

Jun 02, 2026

Target

$12.00

Current

$4.12

Performance

—

XFOR received a Outperform rating from Thomas Smith on Jun 02, 2026, aiming for 12. Price action was muted, as shares hovered around 4.12 despite the bullish outlook.

EQ

Buy

May 28, 2026

Target

$6.00

Current

$2.86

Performance

0.70%

On May 28, 2026, Thomas Smith published a Outperform outlook on EQ, with a target of 6. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 2.86.

SYRE

Buy

Apr 13, 2026

Target

$106.00

Current

$100.32

Performance

58.56%

Thomas Smith on Apr 13, 2026 assigned SYRE a Outperform rating, with a price target of 106. The Buy call aligned well with market performance, producing a gain of 58.56%.

AGMB

Buy

Mar 03, 2026

Target

$36.00

Current

$11.84

Performance

-25.53%

On Mar 03, 2026, Thomas Smith reaffirmed AGMB with a Outperform rating, targeting 36. Shares slid 25.53% despite the recommendation, highlighting downside risks.

RAPT

Hold

Jan 21, 2026

Target

$58.00

Current

$58.01

Performance

0.69%

RAPT was rated Market Perform by Thomas Smith on Jan 21, 2026, with a price objective of 58. Flat performance suggests the Hold view was reasonable.

IVA

Buy

Jan 12, 2026

Target

$12.00

Current

$3.51

Performance

-35.60%

On Jan 12, 2026, Thomas Smith initiated coverage on IVA with a Outperform rating and target of 12. The Buy call has yet to be validated as shares remain 8.49 away from the target.

ALMS

Buy

Jan 07, 2026

Target

$32.00

Current

$24.60

Performance

37.28%

Thomas Smith issued a Outperform recommendation for ALMS on Jan 07, 2026, price target set at 32. Investors following the Buy call captured upside momentum, with shares now at 24.6.

EVMN

Buy

Dec 01, 2025

Target

$42.00

Current

$22.55

Performance

7.84%

On Dec 01, 2025, EVMN was evaluated by Thomas Smith, who gave a Outperform rating and target of 42. This case illustrates how a timely bullish rating can translate into tangible gains of 7.84%.

QTTB

Hold

Dec 11, 2024

Target

$9.00

Current

$12.65

Performance

112.61%

Thomas Smith rated QTTB as Market Perform on Dec 11, 2024, setting a price target of 9. Despite the Hold call, shares climbed 112.61% to 12.65, revealing unexpected momentum.

ACRS

Buy

Nov 19, 2024

Target

$7.00

Current

$4.84

Performance

5.45%

On Nov 19, 2024, ACRS was given a Outperform rating by Thomas Smith, with a target price of 7. The stock rallied 5.45% after the rating, narrowing the gap to the target of 7 and validating the bullish stance.

Frequency Asked Questions

Who is Thomas Smith?

Thomas Smith is an analyst from Leerink Partners specializing in the Healthcare sector.

What is Thomas Smith's success rate?

Thomas Smith currently has a success rate of +74.36%.

How many ratings has Thomas Smith issued?

Thomas Smith has issued 10 stock ratings so far.

What is the average return of Thomas Smith's calls?

Their stock ratings have generated an average return of +29.04%.

What is Thomas Smith's ranking?

Thomas Smith is ranked #1171 out of 4691 analysts.

What types of ratings does Thomas Smith give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Thomas Smith?

You can follow Thomas Smith by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Thomas Smith?

Their latest rating was a Buy on ALT issued on 2026-06-22.